Lyme Disease, Borrelia burgdorferi, Real-time PCR
Also known as: Borrelia burgdorferi
Use
This assay is intended to be used as an aid to the diagnosis of infections caused by Borrelia burgdorferi sensu stricto, the etiologic agent of Lyme disease in the United States. It is not intended to be used for testing patients suspected of acquiring Lyme disease outside of the US.
Special Instructions
Not provided.
Limitations
This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.
Methodology
PCR-based (RT-PCR)
Biomarkers
Borrelia burgdorferi
Microorganism
LOINC Codes
- 4991-6 - B burgdor DNA Spec Ql NAA+probe
- 4991-6 - B burgdor DNA Spec Ql NAA+probe
Result Turnaround Time
4-5 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
0.5 mL
Minimum Volume
0.2 mL
Container
Sterile plastic container
Storage Instructions
CSF and synovial fluid are stable at room temperature or refrigerated for seven days or frozen for 90 days.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 7 days |
| Frozen | 90 days |
Other tests from different labs that may be relevant